Test your knowledge on de novo oligometastatic metastatic HER2+ breast cancer
{"name":"Test your knowledge on de novo oligometastatic metastatic HER2+ breast cancer", "url":"https://www.quiz-maker.com/QQDVX5OXJ","txt":"Which first-line combination therapy was shown to provide benefit for patients with HER2+ metastatic breast cancer in the CLEOPATRA trial?, Patients with oligometastatic breast cancer can have improved survival after receiving curative intent therapy., Which of the following is one of the most common adverse events associated with pertuzumab and trastuzumab therapy?","img":"https://www.quiz-maker.com/3012/images/ogquiz.png"}